Literature DB >> 30685182

Microvascular reconstruction and dental rehabilitation of benign severely atrophic jaws and defects of the alveolar ridge: our philosophy in 2019.

Gian Battista Bottini1, Christian Brandtner2, Christoph Steiner3, Jörn Wittig4, Felix Hartig5, Corina List6, Alexander Gaggl7.   

Abstract

We deal regularly with patients who present with severe atrophy of the jaws, compromised soft tissue, or penetrating defects of the alveolar ridge that are not the result of malignant disease. For these patients we use microvascular bony flaps together with dental implants and implant-supported prostheses. The purpose of this retrospective study was to present our current management and the lessons we have learned over a 16-year period while treating 86 patients for these indications with 87 microvascular bone flaps. We used a transoral approach for the anastomosis in 60 flaps, thereby avoiding visible scars, and inserted 281 dental implants to support fixed or removable dental prostheses. Two femoral flaps developed partial necrosis, and seven implants were lost. Eighty-five of the 86 patients were satisfied with the improvement in their orofacial function and aesthetics. Poor oral hygiene, active osteomyelitis, and severe bruxism are absolute contraindications.
Copyright © 2019 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  alveolar ridge defect; dental implants; dental rehabilitation; free flap; jaw atrophy; microvascular reconstruction

Mesh:

Substances:

Year:  2019        PMID: 30685182     DOI: 10.1016/j.bjoms.2019.01.002

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  1 in total

1.  Extramaxillary Zygomatic Implants: An Alternative Approach for the Reconstruction of the Atrophic Maxilla.

Authors:  Ori Blanc; Dekel Shilo; Efi Weitman; Tal Capucha; Adi Rachmiel
Journal:  Ann Maxillofac Surg       Date:  2020-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.